Clinical Trial Update: Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Modified Si Jun Zi Tang in perioperative treatment for non-small cell lung cancer is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Modified Si Jun Zi Tang (Modified Si Jun Zi Tang)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Non Small Cell Lung Cancer, Perioperative Complication | Phase 2 | Status: RECRUITING